May 4 Ultragenyx Pharmaceutical Inc
* Ultragenyx reports first quarter 2017 financial results and corporate update
* Q1 loss per share $1.63
* Q1 earnings per share view $-1.71 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:
U.S. Marine Corps to resume F-35 operations a day after suspension at Arizona base
June 23 The U.S. Marine Corps said on Friday it resumed flight operations for Lockheed Martin Corp's F-35B fighter jets after temporarily suspended operations a day ago because of software problems.